Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio Francesco Giunta

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Current Opinion in Oncology|April 21, 2021
Anal squamous cell carcinoma: standards of care, new data and ongoing clinical trialsEmilio Francesco Giunta, Giacomo Bregni, Alain Hendlisz, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Liquid biopsy in biliary tract cancer from blood and bile samples: current knowledge and future perspectivesGianluca Arrichiello, Valeria Nacca, Fernando Paragliola, et al.
Frontiers in Medicine|June 13, 2022
First-Line Treatment for Advanced SCLC: What Is Left Behind and Beyond ChemoimmunotherapyEmilio Francesco Giunta, Alfredo Addeo, Alessio Rizzo, et al.
Critical Reviews in Oncology/Hematology|December 20, 2023
Blood-based liquid biopsy in advanced prostate cancerEmilio Francesco Giunta, Umberto Malapelle, Antonio Russo, et al.
Cancer Treatment and Research|January 4, 2024
Transversal Perspectives of Integrative Oncology Care in Gastric and Lobular Breast CancerEmilio Francesco Giunta, Gianluca Arrichiello, Annalisa Pappalardo, et al.
Mediastinum (Hong Kong, China)|March 28, 2022
Standard versus high-dose chemotherapy in mediastinal germ cell tumors: a narrative reviewEmilio Francesco Giunta, Margaret Ottaviano, Alessandra Mosca, et al.
Current Opinion in Pharmacology|November 5, 2022
The emerging role of immunotherapy in the treatment of anal cancerRita Saúde-Conde, Alessandro Parisi, Emilio Francesco Giunta, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 23, 2024
New-generation androgen receptor signaling inhibitors (ARSIs) in metastatic hormone-sensitive prostate cancer (mHSPC): pharmacokinetics, drug-drug interactions (DDIs), and clinical impactLorenzo Gasperoni, Emilio Francesco Giunta, Daniela Montanari, et al.
Cancers|December 23, 2022
Resistance to Antiangiogenic Therapy in Hepatocellular Carcinoma: From Molecular Mechanisms to Clinical ImpactPiera Federico, Emilio Francesco Giunta, Andrea Tufo, et al.
Cancer Treatment Reviews|February 29, 2024
177Lu-PSMA therapy in metastatic prostate cancer: An updated review of prognostic and predictive biomarkersEmilio Francesco Giunta, Nicole Brighi, Giorgia Gurioli, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Current Opinion in Oncology|April 21, 2021
Anal squamous cell carcinoma: standards of care, new data and ongoing clinical trialsEmilio Francesco Giunta, Giacomo Bregni, Alain Hendlisz, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Liquid biopsy in biliary tract cancer from blood and bile samples: current knowledge and future perspectivesGianluca Arrichiello, Valeria Nacca, Fernando Paragliola, et al.
Frontiers in Medicine|June 13, 2022
First-Line Treatment for Advanced SCLC: What Is Left Behind and Beyond ChemoimmunotherapyEmilio Francesco Giunta, Alfredo Addeo, Alessio Rizzo, et al.
Critical Reviews in Oncology/Hematology|December 20, 2023
Blood-based liquid biopsy in advanced prostate cancerEmilio Francesco Giunta, Umberto Malapelle, Antonio Russo, et al.
Cancer Treatment and Research|January 4, 2024
Transversal Perspectives of Integrative Oncology Care in Gastric and Lobular Breast CancerEmilio Francesco Giunta, Gianluca Arrichiello, Annalisa Pappalardo, et al.
Mediastinum (Hong Kong, China)|March 28, 2022
Standard versus high-dose chemotherapy in mediastinal germ cell tumors: a narrative reviewEmilio Francesco Giunta, Margaret Ottaviano, Alessandra Mosca, et al.
Current Opinion in Pharmacology|November 5, 2022
The emerging role of immunotherapy in the treatment of anal cancerRita Saúde-Conde, Alessandro Parisi, Emilio Francesco Giunta, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 23, 2024
New-generation androgen receptor signaling inhibitors (ARSIs) in metastatic hormone-sensitive prostate cancer (mHSPC): pharmacokinetics, drug-drug interactions (DDIs), and clinical impactLorenzo Gasperoni, Emilio Francesco Giunta, Daniela Montanari, et al.
Cancers|December 23, 2022
Resistance to Antiangiogenic Therapy in Hepatocellular Carcinoma: From Molecular Mechanisms to Clinical ImpactPiera Federico, Emilio Francesco Giunta, Andrea Tufo, et al.
Cancer Treatment Reviews|February 29, 2024
177Lu-PSMA therapy in metastatic prostate cancer: An updated review of prognostic and predictive biomarkersEmilio Francesco Giunta, Nicole Brighi, Giorgia Gurioli, et al.
Pageof 6